HEROHE Challenge: Predicting HER2 Status in Breast Cancer from Hematoxylin–Eosin Whole-Slide Imaging

Breast cancer is the most common malignancy in women worldwide, and is responsible for more than half a million deaths each year. The appropriate therapy depends on the evaluation of the expression of various biomarkers, such as the human epidermal growth factor receptor 2 (HER2) transmembrane prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Conde-Sousa, Eduardo, Vale, João, Feng, Ming, Xu, Kele, Wang, Yin, Della Mea, Vincenzo, La Barbera, David, Montahaei, Ehsan, Baghshah, Mahdieh, Turzynski, Andreas, Gildenblat, Jacob, Klaiman, Eldad, Hong, Yiyu, Aresta, Guilherme, Araújo, Teresa, Aguiar, Paulo, Eloy, Catarina, Polónia, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410129/
https://www.ncbi.nlm.nih.gov/pubmed/36005456
http://dx.doi.org/10.3390/jimaging8080213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410129/
https://www.ncbi.nlm.nih.gov/pubmed/36005456
http://dx.doi.org/10.3390/jimaging8080213

Ejemplares similares